enzastaurin has been researched along with decitabine in 1 studies
Studies (enzastaurin) | Trials (enzastaurin) | Recent Studies (post-2010) (enzastaurin) | Studies (decitabine) | Trials (decitabine) | Recent Studies (post-2010) (decitabine) |
---|---|---|---|---|---|
188 | 52 | 99 | 3,804 | 205 | 2,177 |
Protein | Taxonomy | enzastaurin (IC50) | decitabine (IC50) |
---|---|---|---|
DNA (cytosine-5)-methyltransferase 1 | Homo sapiens (human) | 0.03 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hagiwara, K; Ito, H; Miyata, Y; Murate, T; Nagai, H; Ohashi, H | 1 |
1 other study(ies) available for enzastaurin and decitabine
Article | Year |
---|---|
PROX1 overexpression inhibits protein kinase C beta II transcription through promoter DNA methylation.
Topics: Animals; Azacitidine; Cell Proliferation; Decitabine; DNA Methylation; Down-Regulation; Gene Expression Profiling; HCT116 Cells; HeLa Cells; Homeodomain Proteins; Humans; Indoles; Male; Mice; Mice, Inbred BALB C; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Protein Kinase C; Protein Kinase C beta; Sp1 Transcription Factor; Tumor Suppressor Proteins | 2012 |